Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Chinese Journal of Lung Cancer ; (12): 477-487, 2019.
Article in Chinese | WPRIM | ID: wpr-775603

ABSTRACT

BACKGROUND@#Lung cancer rates among women in rural Xuanwei and Fuyuan counties in eastern Yunnan province, China, are among the highest in the world, even though almost all women are non-smokers, and they tend to develop lung cancer at a younger age than other locations by roughly 5 yr-10 yr. This study investigated the survival of lung cancer patients among female never-smokers.@*METHODS@#The female never-smokers, who had lived for many years in Xuanwei and Fuyuan counties, with lung cancer newly-diagnosed between July 2006 to March 2010, were followed up through the end of 2016. Age-standardized relative survival for all cases was calculated using local life table. The Kaplan-Meier method and Log-rank test were used to analyze the relationship between the variables and the prognosis in univariate analysis. Cox regression analysis was employed in the multivariate analysis.@*RESULTS@#Among 1,250 total subjects, 1,075 died and the remaining 175 were censored during the follow-up, with a median follow-up period of 69 months (95%CI: 61.9-76.0). Overall, the mean age was (54.8 ±10.9) yr, with variable clinical stages: 3.5% of cases were stage I, 8.7% stage II, 20.7% stage III, 29.7% stage IV, and 37.4% stage unknown. The 645 patients(51.6%) with cyto-histological diagnosis contains 303 with Squamous cell carcinoma, and 231 with adenocarcinoma, 24 with small cell, 43 with other specified type and 39 with unknown histological type. Only 215 (17.2%) patients received surgery, 487 (39.0%) were treated without surgery, and 548 (43.8%) did not receive any specific anticancer therapy. The 5-year observed survival rate and age-standardized relative survival were 8.9% (95%CI: 7.0-10.6), and 10.1% (95%CI: 3.7-20.5) respectively, with a median survival of 13.2 months. The 5-year survival rates were 41.1% for stage I, 22.4% for stage II, 5.3% for stage III, 1.3% for stage IV, 11.2% for missing stage, 17.9% for adenocarcinoma, and 5.6% for squamous cell carcinoma respectively. Surgery significantly improved 5-year survival rate compared with non-surgery (34.8% vs 3.2%, P<0.001). The patients with non-treatment, aged 65 years and older, living in rural areas and farmer with low socioeconomic status had poorer survival, whereas the patients treated in provincial hospitals and chest X-ray screening had better survival. Cox multivariate analysis further showed that stage of tumor-node-metastasis (TNM), treatment status, hospital-level, and X-ray screening were factors correlated with survival.@*CONCLUSIONS@#Patients with lung cancer among female never-smokers in Xuanwei and Fuyuan experience poorer survival, because they are less likely to be diagnosed at early stage, as well as less likely to receive surgery and comprehensive treatment. Furthermore low socioeconomic status and poor health security are also responsible for the low survival.

2.
Cancer Research and Treatment ; : 1400-1410, 2019.
Article in English | WPRIM | ID: wpr-763220

ABSTRACT

PURPOSE: The aim of this study was to investigate epidemiology, clinical characteristics and sex differences of patients with lung cancer using nationwide registry in Korea. MATERIALS AND METHODS: The Korean Association for Lung Cancer developed a registry in cooperation with the Korean Central Cancer Registry, and surveyed about 10% of lung cancer cases. For this first survey of cases diagnosed in 2014, cases were selected through a systematic sampling method. RESULTS: Total 2,621 lung cancer patients were surveyed, and the median patient age was 70 years. During the study period, adenocarcinoma was the most frequent histologic type, the proportion of female patients was 28.4%, and women had a better prognosis (median survival, not reached vs. 13 months; p<0.001) than did men for non-small cell lung cancer. The proportion of never-smokers was 36.4%, and never-smoking was more prevalent in women than in men (87.5 vs. 16.0%, p<0.001). Epidermal growth factor receptor (EGFR) mutations were found in 36.8% of stage IV adenocarcinoma patients, and higher in female compared to male patients (51.2 vs. 26.6%, p<0.001). In addition, patients with EGFR mutation showed better survival (median survival, 18 vs. 8 months; p<0.001) than patients without EGFR mutation in these patients. CONCLUSION: This is the first survey to gather unbiased nationwide lung cancer statistics in Korea. More than one-third of lung cancer patients had no smoking history. Female had a high proportion of non-smoker, more adenocarcinoma with EGFR mutation and generally better prognosis than male.


Subject(s)
Female , Humans , Male , Adenocarcinoma , Carcinoma, Non-Small-Cell Lung , Epidemiology , Korea , Lung Neoplasms , Lung , Methods , Prognosis , ErbB Receptors , Sex Characteristics , Smoke , Smoking
3.
Cancer Research and Treatment ; : 748-756, 2018.
Article in English | WPRIM | ID: wpr-715830

ABSTRACT

PURPOSE: Because of growing concerns about lung cancer in female never smokers, chest low-dose computed tomography (LDCT) screening is often performed although it has never shown clinical benefits. We examinewhether or not female never smokers really need annual LDCT screening when the initial LDCT showed negative findings. MATERIALS AND METHODS: This retrospective cohort study included 4,365 female never smokers aged 40 to 79 years who performed initial LDCT from Aug 2002 to Dec 2007. Lung cancer diagnosis was identified from the Korea Central Cancer Registry Database registered until December 31, 2013. We calculated the incidence, cumulative probability, and standardized incidence ratio (SIR) of lung cancer by Lung Imaging Reporting and Data System (Lung-RADS) categories showed on initial LDCT. RESULTS: After median follow-up of 9.69 years, 22 (0.5%) had lung cancer. Lung cancer incidence for Lung-RADS category 4 was 1,848.4 (95% confidence interval [CI], 1,132.4 to 3,017.2) per 100,000 person-years and 16.4 (95% CI, 7.4 to 36.4) for categories 1, 2, and 3 combined. The cumulative probability of lung cancer for category 4 was 10.6% at 5 years and 14.8% at 10 years while they were 0.07% and 0.17% when categories 1, 2, and 3 were combined. The SIR for subjects with category 4 was 43.80 (95% CI, 25.03 to 71.14), which was much higher than 0.47 (95% CI, 0.17 to 1.02) for categories 1, 2, and 3 combined. CONCLUSION: Considering the low risk of lung cancer development in female never smokers, it seems unnecessary to repeat annual LDCT screening for at least 5 years or even longer unless the initial LDCT showed Lung-RADS category 4 findings.


Subject(s)
Female , Humans , Cohort Studies , Diagnosis , Follow-Up Studies , Incidence , Information Systems , Korea , Lung Neoplasms , Lung , Mass Screening , Retrospective Studies , Thorax , Tomography, X-Ray Computed
4.
Journal of Korean Medical Science ; : e207-2018.
Article in English | WPRIM | ID: wpr-715777

ABSTRACT

BACKGROUND: Lung cancer in never smokers (LCINS) differs etiologically and clinically from lung cancer attributed to smoking. After smoking, radon exposure is the second leading cause and the primary risk factor of lung cancer among never smokers. Exposure to radon can lead to genetic and epigenetic alterations in tumor genomes affecting genes and pathways involved in lung cancer development. The present study sought to explore genetic alterations associated with LCINS exposed to radon gas indoors. METHODS: Genetic associations were assessed via a case-control study of LCINS (39 cases and 30 controls) using next generation sequencing. Associations between genetic mutations and high exposure to radon were investigated by OncoPrint and heatmap graphs. Bioinformatic analysis was conducted using various tools. According radon exposure levels, we divided subjects in two groups of cases and controls. RESULTS: We found that ABL2 rs117218074, SMARCA4 rs2288845, PIK3R2 rs142933317, MAPK1 rs1803545, and androgen receptor (AR) rs66766400 were associated with LCINS exposed to high radon levels. Among these, Chromodomain helicase DNA-binding protein 4 (CHD4) rs74790047, TSC2 rs2121870, and AR rs66766408 were identified as common exonic mutations in both lung cancer patients and normal individuals exposed to high levels of radon indoor. CONCLUSION: We identified that CHD4 rs74790047, TSC2 rs2121870, and AR rs66766408 are found to be common exonic mutations in both lung cancer patients and normal individuals exposed to radon indoors. Further analysis is needed to determine whether these genes are completely responsible for LCINS exposed to residential radon.


Subject(s)
Humans , Case-Control Studies , Computational Biology , Epigenomics , Exons , Genetic Variation , Genome , Lung Neoplasms , Lung , Radon , Receptors, Androgen , Risk Factors , Smoke , Smoking
5.
Journal of Cancer Prevention ; : 234-240, 2017.
Article in English | WPRIM | ID: wpr-113436

ABSTRACT

BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide, for which smoking is considered as the primary risk factor. The present study was conducted to determine whether genetic alterations induced by radon exposure are associated with the susceptible risk of lung cancer in never smokers. METHODS: To accurately identify mutations within individual tumors, next generation sequencing was conduct for 19 pairs of lung cancer tissue. The associations of germline and somatic variations with radon exposure were visualized using OncoPrint and heatmap graphs. Bioinformatic analysis was performed using various tools. RESULTS: Alterations in several genes were implicated in lung cancer resulting from exposure to radon indoors, namely those in epidermal growth factor receptor (EGFR), tumor protein p53 (TP53), NK2 homeobox 1 (NKX2.1), phosphatase and tensin homolog (PTEN), chromodomain helicase DNA binding protein 7 (CHD7), discoidin domain receptor tyrosine kinase 2 (DDR2), lysine methyltransferase 2C (MLL3), chromodomain helicase DNA binding protein 5 (CHD5), FAT atypical cadherin 1 (FAT1), and dual specificity phosphatase 27 (putative) (DUSP27). CONCLUSIONS: While these genes might regulate the carcinogenic pathways of radioactivity, further analysis is needed to determine whether the genes are indeed completely responsible for causing lung cancer in never smokers exposed to residential radon.


Subject(s)
Cadherins , Computational Biology , DNA-Binding Proteins , Dual-Specificity Phosphatases , Genes, Homeobox , Lung Neoplasms , Lung , Lysine , Radioactivity , Radon , ErbB Receptors , Risk Factors , Smoke , Smoking , TYK2 Kinase
6.
Article in English | IMSEAR | ID: sea-144789

ABSTRACT

Background & objectives: Age adjusted incidence rate of lung cancer in India ranges from 7.4 to 13.1 per 100,000 among males and 3.9 to 5.8 per 100,000 among females. The factors affecting survival in lung cancer patients in India are not fully understood. The current study was undertaken to evaluate the factors affecting survival in patients diagnosed with lung cancer attending a tertiary care cancer institute in Bangalore, Karnataka, India. Methods: Consecutive patients with primary lung cancer attending Bangalore Institute of Oncology, a tertiary care centre at Bangalore, between 2006 and 2009 were included. Demographic, clinical, radiological data were collected retrospectively from the medical records. Results: A total of 170 consecutive subjects (128 males, 42 females) diagnosed to have lung cancer; 151 non-small cell lung cancer (NSCLC) and 19 small cell lung cancer (SCLC) were included. A higher proportion of never-smokers (54.1%) were observed, mostly presenting below the age of 60 yr. Most subjects were in stage IV and III at the time of diagnosis. More than 50 per cent of patients presented with late stage lung cancer even though the duration of symptoms is less than 2 months. The 30-month overall survival rates for smokers and never-smokers were 32 and 49 per cent, respectively. No significant differences were observed in 30 month survival based on age at presentation, gender and type of lung cancer. Cox proportional hazards model identified never-smokers and duration of symptoms less than 1 month as factors adversely affecting survival. Interpretation & conclusions: Our results showed that lung cancer in Indians involved younger subjects and associated with poorer survival as compared to other ethnic population. Studies on large sample need to be done to evaluate risk factors in lung cancer patients.


Subject(s)
Adult , Humans , India/epidemiology , Lung Neoplasms/mortality , Middle Aged , Mortality , Small Cell Lung Carcinoma/mortality , Smoking , Survival Rate , Tertiary Care Centers , Young Adult
7.
Indian J Cancer ; 2012 Jan-Mar; 49(1): 82-88
Article in English | IMSEAR | ID: sea-144556

ABSTRACT

Background: Lung cancer remains a major cause of morbidity and mortality worldwide, accounting for more deaths than any other cancer cause. Aim: The aim of this study was to analyze the clinical profile and the epidemiological trends in lung cancer patients from a single centre with an emphasis on the smoking practices. Materials and Methods: This is a retrospective analysis of prospectively collected data of 258 consecutive hospital in-patients with a proven diagnosis of lung cancer at a tertiary care oncology centre between 2003 and 2007. Results: The median age of patients in our study was 56 years; the male to female ratio was approximately 3.5:1. Non-small-cell lung cancer (NSCLC) was the predominant histology in 224 patients; the histology in the remaining 34 patients was small-cell carcinoma. Within NSCLC, the most common histology was adenocarcinoma followed by squamous cell carcinoma. One hundred and two patients were never-smokers as compared to 156 patients who were ever-smokers. Among the smokers, the majority of them were found to be cigarette smokers compared to 28.2% bidi smokers. There was a very significant correlation found with adenocarcinoma among nonsmokers, and with squamous cell carcinoma among the smokers compared to non-smokers. Conclusions: Our study suggests that the epidemiology of lung cancer in India is possibly changing, with close to 40% of our lung cancer patients being nonsmokers. More importantly, our study reflects the global trend of rise in adenocarcinoma histology. These observations need to be substantiated in similar studies of larger magnitude, preferably population-based.


Subject(s)
Adult , Aged , Carcinoma, Non-Small-Cell Lung/epidemiology , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Small Cell/epidemiology , Carcinoma, Small Cell/pathology , Female , Humans , India/epidemiology , Kaplan-Meier Estimate , Lung Neoplasms/epidemiology , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Risk Factors , Smoking/epidemiology
8.
Salud pública Méx ; 52(supl.2): S108-S119, 2010. graf, tab
Article in Spanish | LILACS | ID: lil-571803

ABSTRACT

Objetivo. Describir las tendencias, durante las pasadas dos décadas, de varios indicadores de tabaquismo y explorar si las políticas de contención de la epidemia de tabaquismo en México, implantadas desde 2004, han tenido ya un impacto favorable hacia 2008. Material y métodos. Se analizan las tendencias de datos comparables sobre la prevalencia de nunca fumadores y de fumadores diarios, utilizando las cinco encuestas nacionales de adicciones realizadas entre 1988 y 2008. En el análisis se incluye a personas entre 18 y 65 años de edad y se realizan ajustes por índice de marginación, edad y sexo. Resultados. Entre 2002 y 2008 aumentó en 19.6 por ciento el porcentaje de nunca fumadores y disminuyó 24.8 por ciento el porcentaje de fumadores diarios. Estos cambios fueron más importantes en los hombres que en las mujeres, pero en estas últimas se redujo en el mismo periodo en 21.1 por ciento el promedio de cigarrillos fumados a diario y se incrementó en 13.9 por ciento el porcentaje que había intentado dejar de fumar. La prevalencia de fumadores diarios se ha reducido más aceleradamente desde 2005, lo que coincide con el incremento en los impuestos a los cigarrillos. Conclusiones. Se observa en México, durante las dos últimas décadas, una tendencia al incremento del porcentaje de nunca fumadores y a la reducción del porcentaje de fumadores diarios. A pocos años de haberse implantado en México políticas de control del tabaquismo más efectivas, en particular el incremento en los impuestos al tabaco, se observan ya resultados favorables.


Objetive. To describe the changes in several smoking indicators occurred in Mexico over the past two decades and to explore if the tobacco control policies implemented in Mexico, since 2004, show a favorable impact on tobacco consumption by 2008. Materials and Methods. We analyze trends in comparable data on the prevalence of never and daily smokers, using the five National Addiction Surveys conducted between 1988 and 2008. The analysis is restricted to persons aged 18 through 65 years. Data are adjusted for age, sex and marginality index. Results. Between 2002 and 2008 the percentage of never smokers has increased by 19.6 percent and the percentage of daily smokers has decreased by 24.8 percent. These changes were more important in men, but in women the average number of cigarettes consumed decreased by 21.1 percent over the compared period and there was also a 13.9 percent rise in the percentage of women attempting to quit. Daily smokers prevalence has declined more rapidly since 2005, coincidently with an increase in cigarette taxation. Conclusions. Over the past two decades there has been in Mexico an increase in the percentage of never smokers and a decline in the percentage of daily smokers. A positive impact is observed, few years after the implementation of more effective tobacco control policies in Mexico, notably higher taxation of tobacco products.


Subject(s)
Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Smoking/epidemiology , Mexico/epidemiology , Prevalence , Retrospective Studies , Smoking/prevention & control , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL